Dagmar E. Ehrnhoefer
AbbVie (Germany)(DE)
Publications by Year
Research Areas
Mitochondrial Function and Pathology, Genetic Neurodegenerative Diseases, Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Muscle Physiology and Disorders
Most-Cited Works
- → EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers(2008)1,407 cited
- → EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity(2010)993 cited
- → Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin(2009)427 cited
- → Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models(2006)413 cited
- → Autophagy in Huntington disease and huntingtin in autophagy(2014)334 cited
- → Small Changes, Big Impact(2011)181 cited
- → Caspase-6 and neurodegeneration(2011)129 cited
- → A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain(2019)119 cited
- → HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response(2014)106 cited
- → Mouse models of Huntington disease: variations on a theme(2009)100 cited